Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a  prospective multicentre phase 1/2 clinical trial

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - September 14, 2018 Category: Hematology Authors: Lihua E. Budde , David Wu , Daniel B. Martin , Mary Philip , Andrei R. Shustov , Stephen D. Smith , Ted A. Gooley , Tara L. Chen , Edward N. Libby , Eric Y. Chen , Kiarash Kojouri , Alan Langerak , Jennifer E. Roden , Oliver W. P Source Type: research